Rene Gonzalez Selected Research

Rene Gonzalez Research Topics

Disease

98	Melanoma (Melanoma, Malignant) 10/2022 - 01/2002
40	Neoplasms (Cancer) 02/2022 - 01/2007
8	Disease Progression 10/2018 - 11/2009
6	Body Weight (Weight, Body) 10/2019 - 08/2010
6	Neoplasm Metastasis (Metastasis) 01/2018 - 12/2009
5	Fatigue 08/2015 - 06/2009
4	Neutropenia 11/2018 - 01/2010
4	Brain Neoplasms (Brain Tumor) 10/2018 - 06/2011
3	Pneumonia (Pneumonitis) 01/2021 - 08/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2012
3	Fever (Fevers) 10/2019 - 02/2011
3	Arthralgia (Joint Pain) 10/2019 - 02/2011
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 04/2011
3	Colitis 11/2018 - 08/2015
3	Thrombocytopenia (Thrombopenia) 06/2014 - 06/2009
3	Carcinogenesis 10/2012 - 09/2011
2	Exanthema (Rash) 10/2019 - 08/2014
2	Myalgia 08/2015 - 08/2014
2	Nausea 08/2014 - 02/2011
2	Circulating Neoplastic Cells 04/2010 - 02/2006
1	Lung Injury 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Infections 01/2021
1	Erythema Nodosum 10/2019
1	Necrosis 11/2018

Drug/Important Bio-Agent (IBA)

22	IpilimumabIBA 10/2022 - 08/2010
13	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2012
11	NivolumabIBA 10/2022 - 08/2014
11	VemurafenibIBA 01/2020 - 12/2011
11	Interleukin-2 (IL2)IBA 01/2019 - 01/2002
9	trametinibIBA 01/2020 - 08/2012
8	Peptides (Polypeptides)IBA 02/2022 - 12/2011
7	Type 1 Melanocortin ReceptorIBA 02/2022 - 11/2018
7	Pharmaceutical PreparationsIBA 01/2019 - 04/2009
6	LactamsIBA 01/2022 - 01/2019
6	dabrafenibIBA 01/2018 - 11/2012
6	Dacarbazine (DIC)FDA LinkGeneric 08/2014 - 05/2008
5	alpha-MSHIBA 02/2022 - 01/2019
5	AcidsIBA 02/2022 - 01/2020
5	pembrolizumabIBA 12/2021 - 08/2014
5	Immune Checkpoint InhibitorsIBA 01/2019 - 12/2016
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2007
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016 - 01/2005
5	Imatinib Mesylate (Gleevec)FDA Link 05/2015 - 01/2007
5	Monoclonal AntibodiesIBA 01/2014 - 03/2010
4	triazacyclononaneIBA 01/2022 - 01/2020
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 06/2010
4	CTLA-4 AntigenIBA 01/2019 - 08/2010
4	AntibodiesIBA 08/2014 - 11/2008
4	Temozolomide (Temodar)FDA LinkGeneric 10/2012 - 01/2005
3	Melanocyte-Stimulating Hormones (MSH)IBA 01/2022 - 11/2019
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022 - 01/2020
3	cobimetinibIBA 01/2020 - 08/2014
3	LigandsIBA 01/2019 - 08/2014
3	SurvivinIBA 05/2015 - 04/2009
3	Allovectin-7IBA 01/2011 - 12/2006
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2010 - 06/2009
2	AlbuminsIBA 02/2022 - 01/2010
2	Chelating AgentsIBA 12/2020 - 01/2020
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 12/2020 - 01/2020
2	RNA (Ribonucleic Acid)IBA 07/2020 - 01/2007
2	Interleukin-8 (Interleukin 8)IBA 01/2019 - 10/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 11/2008
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2018 - 10/2012
2	Messenger RNA (mRNA)IBA 01/2018 - 11/2005
2	sepantroniumIBA 05/2015 - 02/2011
2	Biomarkers (Surrogate Marker)IBA 10/2012 - 04/2010
2	Small Interfering RNA (siRNA)IBA 10/2012 - 02/2012
2	HLA-A*02:01 antigenIBA 12/2011 - 08/2010
2	Protein Subunit VaccinesIBA 06/2011 - 08/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2010 - 11/2005
2	Sorafenib (BAY 43-9006)FDA Link 06/2009 - 05/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2009 - 10/2007
2	phosphomannopentaose sulfateIBA 11/2008 - 02/2008
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2022
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	Chemokine CXCL10IBA 12/2021
1	Toll-Like Receptor 9IBA 12/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	HLA-A Antigens (HLA-A)IBA 01/2021
1	(2-boronoethyl)-cysteineIBA 01/2021
1	ArginaseIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	phenylalanylarginineIBA 12/2020
1	MetalsIBA 01/2020
1	GSK2141795IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	SteroidsIBA 01/2019
1	atezolizumabIBA 01/2019
1	CytokinesIBA 01/2019
1	Radioisotopes (Radionuclides)IBA 11/2018

Therapy/Procedure

43	Therapeutics 01/2022 - 10/2007
13	Drug Therapy (Chemotherapy) 11/2017 - 01/2002
9	Immunotherapy 01/2021 - 04/2009
5	Lymph Node Excision (Lymph Node Dissection) 05/2014 - 01/2005
2	Intravenous Infusions 11/2017 - 11/2009
2	Radiotherapy 01/2014 - 04/2011
2	Biological Therapy 04/2010 - 12/2009
1	Precision Medicine 01/2022